ES2001516A6 - Un procedimiento para preparar derivados de 7-oxo-4-tia-1-azabiciclo(3,2,o)hept-2-eno - Google Patents

Un procedimiento para preparar derivados de 7-oxo-4-tia-1-azabiciclo(3,2,o)hept-2-eno

Info

Publication number
ES2001516A6
ES2001516A6 ES8601112A ES8601112A ES2001516A6 ES 2001516 A6 ES2001516 A6 ES 2001516A6 ES 8601112 A ES8601112 A ES 8601112A ES 8601112 A ES8601112 A ES 8601112A ES 2001516 A6 ES2001516 A6 ES 2001516A6
Authority
ES
Spain
Prior art keywords
group
groups
phenyl
carbon atoms
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8601112A
Other languages
English (en)
Inventor
Michael David Cooke
Stephen Connolly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Hoechst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst UK Ltd filed Critical Hoechst UK Ltd
Publication of ES2001516A6 publication Critical patent/ES2001516A6/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

EL PROCEDIMIENTO DESCRITO PREPARA COMPUESTOS DE FORMULA DONDE R REPRESENTA HIDROGENO O UN GRUPO ESTERIFICADOR DE ACIDO CARBOXILICO, R1 REPRESENTA CIANO, NITRO O UN RADICAL ORGANICO, R2 REPRESENTA HIDROGENO, HALOGENO, CIANO, NITRO O UN RADICAL ORGANICO Y R3 REPRESENTA HIDROGENO O UN GRUPO PROTECTOR DE HIDROXI, HACIENDO REACCIONAR UN COMPUESTO DE FORMULA DONDE R3 ES COMO ANTES, R4 ES UN GRUPO PROTECTOR DE CARBOXI, R5 ES UN GRUPO R1 O UN GRUPO CONVERTIBLE EN R1, R6 ES UN GRUPO R2 O UN GRUPO CONVERTIBLE EN R2, R7 ES FENILO O ALQUILO Y R8 ES BROMO O CLORO, CON UNA BASE TAL COMO AMONIACO, CARBONATO, BICARBONATO O HIDROXIDO DE METAL ALCALINO Y OTROS COMPUESTOS BASICOS. LOS COMPUESTOS OBTENIDOS SE PUEDEN INCORPORAR EN FORMULACIONES FARMACEUTICAS DEBIDO A SU ACTIVIDAD ANTIBACTERIANA.
ES8601112A 1985-08-16 1986-08-14 Un procedimiento para preparar derivados de 7-oxo-4-tia-1-azabiciclo(3,2,o)hept-2-eno Expired ES2001516A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858520631A GB8520631D0 (en) 1985-08-16 1985-08-16 Derivatives

Publications (1)

Publication Number Publication Date
ES2001516A6 true ES2001516A6 (es) 1988-06-01

Family

ID=10583916

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8601112A Expired ES2001516A6 (es) 1985-08-16 1986-08-14 Un procedimiento para preparar derivados de 7-oxo-4-tia-1-azabiciclo(3,2,o)hept-2-eno

Country Status (15)

Country Link
EP (1) EP0212404A1 (es)
JP (1) JPS6245589A (es)
KR (1) KR870002147A (es)
AU (1) AU593829B2 (es)
DK (1) DK388986A (es)
ES (1) ES2001516A6 (es)
FI (1) FI863300A (es)
GB (1) GB8520631D0 (es)
GR (1) GR862138B (es)
IL (1) IL79716A0 (es)
NO (1) NO863304L (es)
NZ (1) NZ217202A (es)
PH (1) PH24057A (es)
PT (1) PT83197A (es)
ZA (1) ZA866161B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0597401A3 (en) * 1992-11-11 1995-07-26 Takeda Chemical Industries Ltd Preparation of penemes.
US6395894B2 (en) 1998-04-16 2002-05-28 Philip J. Pye Process for the synthesis of carbapenem intermidiates, and compounds produced
ATE263766T1 (de) 1998-06-17 2004-04-15 Merck & Co Inc Verfahren zur synthese von carbapenem- zwischenprodukten
US6194568B1 (en) 1998-07-13 2001-02-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
JP4349913B2 (ja) * 2002-03-26 2009-10-21 日本曹達株式会社 環状化合物の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168314A (en) * 1977-11-17 1979-09-18 Merck & Co., Inc. 6-(1'-Hydroxyethyl)-2-aminoethylthio-pen-2-em-3-carboxylic acid
JPS5625110A (en) * 1978-12-18 1981-03-10 Bristol Myers Co Antibacterial
DE3277696D1 (en) * 1981-07-15 1987-12-23 Sumitomo Pharma Carboxylic beta-lactam compounds and the preparation thereof
GB2164334B (en) * 1984-09-10 1988-08-03 Hoechst Uk Ltd Antibacterial 7-oxo-4-thia-1-azabicyclo 3,2,0 hept-2-ene derivativess

Also Published As

Publication number Publication date
DK388986D0 (da) 1986-08-15
AU6151086A (en) 1987-02-19
EP0212404A1 (en) 1987-03-04
NO863304L (no) 1987-02-17
NZ217202A (en) 1989-08-29
NO863304D0 (no) 1986-08-15
PH24057A (en) 1990-03-05
JPS6245589A (ja) 1987-02-27
DK388986A (da) 1987-02-17
IL79716A0 (en) 1986-11-30
GR862138B (en) 1986-12-30
KR870002147A (ko) 1987-03-30
ZA866161B (en) 1987-04-29
AU593829B2 (en) 1990-02-22
PT83197A (en) 1986-09-01
FI863300A (fi) 1987-02-17
GB8520631D0 (en) 1985-09-25
FI863300A0 (fi) 1986-08-14

Similar Documents

Publication Publication Date Title
ES473074A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina
IE42409L (en) Acetylene derivatives of aminoacids.
AU539399B2 (en) Substituted oxonicotinates
GB1503077A (en) Quaternary imidazolium compounds and their use as microbicides
AU1233188A (en) Deuterated aryl aldehydes and derivatives thereof
ES2001516A6 (es) Un procedimiento para preparar derivados de 7-oxo-4-tia-1-azabiciclo(3,2,o)hept-2-eno
GB1169945A (en) Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives
FR2394584A1 (fr) Melanges de composes azoiques utilisables comme pigments
DK0547231T3 (da) Phospholipase-A2-inhibitor
GB1495305A (en) 3-phenyl-4-oxo-4h-benzopyran derivatives
GB1461667A (en) Amphetamine derivatives
ES456400A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina.
SE8405812D0 (sv) Mellanprodukter for framstellning av nya 2-substituerade och 2,6-disubstituerade penem-foreningar
GB1416415A (en) Biphenyl compounds and their use as light protective agents
ES8707963A1 (es) Un procedimiento para preparar derivados de penem
ES8103077A1 (es) Procedimiento de preparacion de nuevos derivados fenotiazi- nos o de sus sales de adicion acidas
KR860007264A (ko) 새로운 1-옥사-1-데티아 세팔로스포린 화합물의 제조방법
GB1472652A (en) Piperazinyl esters of n-quinelylanthranilic acid
GB1139629A (en) Cyclopentanone derivatives
ES8603393A1 (es) Procedimiento para preparar composiciones fungicidas
GB1076966A (en) 2-aminoindane derivatives
GB1499193A (en) Indolino-spiropyran compounds useful as colour formers
GB1501588A (en) 4,5-disubstituted 2-oxazolealkanoic acids esters and alkali metal salts
JPS5251345A (en) Peparation of novel cyclopentanone derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980401